COVIVIO (COV.PA) Forecast, Price Target & Analyst Ratings

EPA:COV • FR0000064578

Current stock price

58.15 EUR
-0.45 (-0.77%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for COVIVIO (COV.PA).

Forecast Snapshot

Consensus Price Target

Price Target
€64.17
+ 10.35% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Jul 21, 2026
Period
Q2 / 2026
EPS Estimate
€2.34
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
74.67%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€64.17
Upside
+ 10.35%
From current price of €58.15 to mean target of €64.17, Based on 15 analyst forecasts
Low
€56.06
Median
€64.77
High
€73.50

Price Target Revisions

1 Month
-0.17%
3 Months
-0.84%

Price Target Summary

15 Wall Street analysts provided a forecast for the next 12 months for COV.PA. The average price target is 64.17 EUR. This implies a price increase of 10.35% is expected in the next year compared to the current price of 58.15.
The average price target has been revised downward by 0.84% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

COV Current Analyst RatingCOV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

COV Historical Analyst RatingsCOV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
74.67%
COV.PA was analyzed by 15 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about COV.PA.
In the previous month the buy percentage consensus was at a similar level.
COV.PA was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-08-30BNP PARIBAS EXANEMaintains Neutral -> Neutral

Next Earnings Forecast Details

Next Earnings Details

Release Date
Jul 21, 2026
Period
Q2 / 2026
EPS Estimate
€2.34
Revenue Estimate
N/A
Revenue Q2Q
N/A
EPS Q2Q
-1.55%
Number of Analysts
2

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

COV.PA is expected to report earnings on 7/21/2026. The consensus EPS estimate for the next earnings is 2.34 EUR and the consensus revenue estimate is null EUR.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
COV.PA revenue by date.COV.PA revenue by date.
863.5M
-26.49%		1.301B
50.70%		1.423B
9.31%		710.88M
-50.03%		751.59M
5.73%		896.29M
19.25%
EBITDA
YoY % growth
COV.PA ebitda by date.COV.PA ebitda by date.
860.556M
3.45%		911.1M
5.87%		948.8M
4.14%		666.86M
-29.72%		703.76M
5.53%		749.16M
6.45%
EBIT
YoY % growth
COV.PA ebit by date.COV.PA ebit by date.
791M
2.79%		796.4M
0.68%		804.8M
1.05%		645.94M
-19.74%		700.62M
8.47%		763.7M
9.00%
Operating Margin
COV.PA operating margin by date.COV.PA operating margin by date.
91.60%61.20%56.58%90.86%93.22%85.21%
EPS
YoY % growth
COV.PA eps by date.COV.PA eps by date.
4.47
-2.40%		4.47
0.00%		4.75
6.26%		4.94
3.92%		5.11
3.62%		5.28
3.14%

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 26 Q4 / 26 Q2 / 27 Q4 / 27
EPS
Q2Q % growth		2.34
-1.55%		2.59
9.10%		2.39
2.16%		2.62
1.17%
Revenue
Q2Q % growth		N/AN/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		498.58M
25.71%		494.34M
21.01%		N/AN/A

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

COV.PA Yearly Revenue VS EstimatesCOV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
COV.PA Yearly EPS VS EstimatesCOV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
3.56%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
9.64%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
6.51%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

COVIVIO / COV.PA Forecast FAQ

What do analysts expect the price target to be for COVIVIO (COV.PA)?

15 analysts have analysed COV.PA and the average price target is 64.17 EUR. This implies a price increase of 10.35% is expected in the next year compared to the current price of 58.15.

What is the next earnings date for COV stock?

COVIVIO (COV.PA) will report earnings on 2026-07-21.

What is the expected long term growth rate for COV stock?

The expected long term growth rate for COVIVIO (COV.PA) is 9.64%.